🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

208 results for “Jazz Pharmaceuticals Ireland Limited” Clear

  1. CPX-351

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukemia (AML) in Remission

    phase 2 small molecule active

    1 trial

  2. CPX-351

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukemia (AML)

    phase 2 small molecule completed

    2 trials

  3. CPX-351

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukemia

    phase 2 small molecule completed

    7 trials

  4. CX-8998

    Jazz Pharmaceuticals Ireland Limited

    Parkinson's Disease

    phase 2 small molecule terminated

    1 trial

  5. CX-8998

    Jazz Pharmaceuticals Ireland Limited

    Essential Tremor

    phase 2 small molecule completed

    1 trial

  6. CX-8998

    Jazz Pharmaceuticals Ireland Limited

    Epilepsy

    phase 2 small molecule completed

    1 trial

  7. Cannabidiol

    Jazz Pharmaceuticals Ireland Limited

    Sturge-Weber Syndrome

    phase 2 small molecule completed

    2 trials

  8. Cannabidiol

    Jazz Pharmaceuticals Ireland Limited

    Early Life Adversity

    phase 2 small molecule active

    1 trial

  9. Cannabidivarin

    Jazz Pharmaceuticals Ireland Limited

    Autism Spectrum Disorder

    phase 2 small molecule active

    1 trial

  10. Caphosol

    Jazz Pharmaceuticals Ireland Limited

    Oral Mucositis

    phase 2 other active

    1 trial

  11. Clonazepam

    Jazz Pharmaceuticals Ireland Limited

    Epilepsy

    phase 2 small molecule completed

    1 trial

  12. Cytarabine

    Jazz Pharmaceuticals Ireland Limited

    Leukemia

    phase 2 small molecule terminated

    1 trial

  13. Cytarabine and Idarubicin

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  14. Defibrotide

    Jazz Pharmaceuticals Ireland Limited

    Graft-versus-host Disease

    phase 2 small molecule completed

    1 trial

  15. Defibrotide

    Jazz Pharmaceuticals Ireland Limited

    DLBCL

    phase 2 small molecule terminated

    1 trial

  16. Defibrotide

    Jazz Pharmaceuticals Ireland Limited

    Covid19

    phase 2 small molecule active

    1 trial

  17. Defibrotide

    Jazz Pharmaceuticals Ireland Limited

    Transplant-Associated Thrombotic Microangiopathy

    phase 2 small molecule terminated

    1 trial

  18. Dociparstat sodium

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukemia

    phase 2 small molecule completed

    1 trial

  19. Dordaviprone (ONC201)

    Jazz Pharmaceuticals Ireland Limited

    Glioma

    phase 2 small molecule terminated

    1 trial

  20. Dordaviprone (ONC201)

    Jazz Pharmaceuticals Ireland Limited

    Glioblastoma

    phase 2 small molecule terminated

    1 trial

  21. Dordaviprone (ONC201)

    Jazz Pharmaceuticals Ireland Limited

    Endometrial Cancer Recurrent

    phase 2 small molecule terminated

    1 trial

  22. Enasidenib Mesylate

    Jazz Pharmaceuticals Ireland Limited

    Recurrent Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  23. Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase)

    Jazz Pharmaceuticals Ireland Limited

    Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)

    phase 2 small molecule terminated

    1 trial

  24. Fludarabine

    Jazz Pharmaceuticals Ireland Limited

    Hematologic Malignancy

    phase 2 small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources